Dietary Supplement Reduces Heart Lesions
Dietary Supplement Found for Remarkable Regression in Atherosclerotic Lesions
Tags: Osaka University, Japan, Healthcare & Lifesciences
A supplement, tricaprin, has been discovered to reverse heart disease signs in some patients by promoting lipid breakdown. This discovery addresses triglyceride deposit cardiomyovasculopathy (TGCV), a CAD type resistant to standard treatments. Tricaprin's intake led to symptom relief and regression of triglyceride build-up in heart vessels. This novel approach offers hope for CAD patients unresponsive to conventional therapies, suggesting a multi-faceted treatment strategy.
IP Type or Form Factor: Discovery & Research
TRL: Not specified
Industry or Tech Area: Pharmaceutical Engineering; Healthcare Provider
